Aperio Therapeutics Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $581K

  • Investors
  • 2

Aperio Therapeutics General Information

Description

Developer of biology-driven therapies designed to break the self-starvation cycle associated with anorexia nervosa. The company is currently operating in Stealth Mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Doktor-Bohr-Gasse 7
  • Vienna, 1030
  • Austria
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Doktor-Bohr-Gasse 7
  • Vienna, 1030
  • Austria

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aperio Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 16-Sep-2026 $581K Completed Stealth
To view Aperio Therapeutics’s complete valuation and funding history, request access »

Aperio Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioInnovation Institute Accelerator/Incubator
Xista Science Ventures Venture Capital Minority
To view Aperio Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Aperio Therapeutics FAQs

  • When was Aperio Therapeutics founded?

    Aperio Therapeutics was founded in 2026.

  • Where is Aperio Therapeutics headquartered?

    Aperio Therapeutics is headquartered in Vienna, Austria.

  • What industry is Aperio Therapeutics in?

    Aperio Therapeutics’s primary industry is Drug Delivery.

  • Is Aperio Therapeutics a private or public company?

    Aperio Therapeutics is a Private company.

  • What is Aperio Therapeutics’s current revenue?

    The current revenue for Aperio Therapeutics is .

  • How much funding has Aperio Therapeutics raised over time?

    Aperio Therapeutics has raised $581K.

  • Who are Aperio Therapeutics’s investors?

    BioInnovation Institute and Xista Science Ventures have invested in Aperio Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process